{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:43:23Z","timestamp":1751471003177},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/mph.0000000000000549","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T18:06:15Z","timestamp":1457201175000},"page":"167-172","source":"Crossref","is-referenced-by-count":7,"title":["Significance of BAFF\/APRIL Expression and Their Receptors in Pediatric Patients With Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"38","author":[{"given":"Baolan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210209","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","article-title":". Biology, risk stratification, and therapy of pediatric acute leukemias: an update.","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"key":"R2-1-20210209","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bcmd.2007.04.005","article-title":". Integrating molecular information into treatment of childhood acute lymphoblastic leukemiaa perspective from the BFM study group.","volume":"39","author":"Stanulla","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"R3-1-20210209","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4614-6176-0_15","article-title":"Genetic targets in pediatric acute lymphoblastic leukemia.","volume":"779","author":"Gowda","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"R4-1-20210209","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2012.01.007","article-title":"Perspectives on the causes of childhood leukemia.","volume":"196","author":"Wiemels","year":"2012","journal-title":"Chem Biol Interact"},{"key":"R5-1-20210209","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":". BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"key":"R6-1-20210209","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","article-title":". APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.","volume":"188","author":"Hahne","year":"1998","journal-title":"J Exp Med"},{"key":"R7-1-20210209","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation.","volume":"17","author":"Schneider","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R8-1-20210209","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.cyto.2012.10.018","article-title":". APRIL stimulates NF-kappaB-mediated HoxC4 induction for AID expression in mouse B cells.","volume":"61","author":"Park","year":"2013","journal-title":"Cytokine"},{"key":"R9-1-20210209","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bjh.12645","article-title":". B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.","volume":"164","author":"Ferrer","year":"2014","journal-title":"Br J Haematol"},{"key":"R10-1-20210209","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-10-10","article-title":". BAFFAPRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy.","volume":"10","author":"Pranzatelli","year":"2013","journal-title":"J Neuroinflammation"},{"key":"R11-1-20210209","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.1102066","article-title":". Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.","volume":"188","author":"Cols","year":"2012","journal-title":"J Immunol"},{"key":"R12-1-20210209","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00277-013-1924-9","article-title":". BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.","volume":"93","author":"Bolkun","year":"2014","journal-title":"Ann Hematol"},{"key":"R13-1-20210209","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.leukres.2013.05.014","article-title":". Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features.","volume":"37","author":"Lemancewicz","year":"2013","journal-title":"Leuk Res"},{"key":"R14-1-20210209","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1182\/blood-2008-09-179762","article-title":". A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclinD1 expression through phosphatidylinositol 3-kinase regulated mammalian target of rapamycin activation.","volume":"113","author":"Gupta","year":"2009","journal-title":"Blood"},{"key":"R15-1-20210209","first-page":"225","article-title":"Belimumab therapy in systemic lupus erythematosus.","volume":"27","author":"Zouali","year":"2013","journal-title":"Bio Drugs"},{"key":"R16-1-20210209","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":". Efficacy and safety of belimumab in primary Sjogrens syndrome: results of the BELISS open-label phase II study.","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R17-1-20210209","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1182\/blood-2011-01-330852","article-title":". Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.","volume":"117","author":"Guadagnoli","year":"2011","journal-title":"Blood"},{"key":"R18-1-20210209","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/10428190903013334","article-title":"B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity.","volume":"50","author":"Ferrer","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R19-1-20210209","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3109\/10428194.2011.591008","article-title":". Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia.","volume":"52","author":"Ferrer","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R20-1-20210209","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":". TACI is mutant in common variable immunodeficiency and IgA deficiency.","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"R21-1-20210209","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Regulated expression of BAFF-binding receptors during human B cell differentiation.","volume":"179","author":"Darce","year":"2007","journal-title":"J Immunol"},{"key":"R22-1-20210209","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.leukres.2009.03.030","article-title":"BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.","volume":"33","author":"Bojarska-Junak","year":"2009","journal-title":"Leuk Res"},{"key":"R23-1-20210209","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/asheducation-2011.1.96","article-title":"Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.","volume":"2011","author":"Burger","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R24-1-20210209","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2004-03-0889","article-title":"Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-lalpha.","volume":"106","author":"Nishio","year":"2005","journal-title":"Blood"},{"key":"R25-1-20210209","doi-asserted-by":"crossref","first-page":"e60370","DOI":"10.1371\/journal.pone.0060370","article-title":"A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.","volume":"8","author":"Ghamlouch","year":"2013","journal-title":"PLoS One"},{"key":"R26-1-20210209","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1053\/j.seminhematol.2013.03.021","article-title":"Immune thrombocytopenia and B-cell-activating factora proliferation inducing ligand.","volume":"50","author":"Liu","year":"2013","journal-title":"Semin Hematol"},{"key":"R27-1-20210209","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd1982","article-title":"An APRIL to remember: novel TNF ligands as therapeutic targets.","volume":"5","author":"Dillon","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"R28-1-20210209","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/14728222.2014.888415","article-title":"Therapeutic targeting of the BAFFAPRIL axis in systemic lupus erythematosus.","volume":"18","author":"Stohl","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"R29-1-20210209","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/eji.201040591","article-title":". Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody response.","volume":"41","author":"Bossen","year":"2011","journal-title":"Eur J Immunol"},{"key":"R30-1-20210209","doi-asserted-by":"crossref","first-page":"301","DOI":"10.33549\/physiolres.930816","article-title":". Effects of human soluble BAFF synthesized in Escherichia coli on CD4 and CD8 T lymphocytes as well as NK cells in mice.","volume":"55","author":"Shan","year":"2006","journal-title":"Physiol Res"},{"key":"R31-1-20210209","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/embo-reports\/kve198","article-title":". Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase.","volume":"2","author":"Lopez-Fraga","year":"2001","journal-title":"EMBO Rep"},{"key":"R32-1-20210209","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.165.3.1322","article-title":"TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF)1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.","volume":"165","author":"Hatzoglou","year":"2000","journal-title":"J Immunol"},{"key":"R33-1-20210209","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1102891","article-title":"APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2M cell growth arrest in liver cells.","volume":"189","author":"Notas","year":"2012","journal-title":"J Immunol"},{"key":"R34-1-20210209","doi-asserted-by":"crossref","first-page":"e83250","DOI":"10.1371\/journal.pone.0083250","article-title":". BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.","volume":"8","author":"Pelekanou","year":"2013","journal-title":"PLoS One"},{"key":"R35-1-20210209","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/79802","article-title":". APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity.","volume":"1","author":"Yu","year":"2000","journal-title":"Nat Immunol"},{"key":"R36-1-20210209","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","article-title":". BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"R37-1-20210209","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.transci.2011.01.009","article-title":"Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance.","volume":"44","author":"Graux","year":"2011","journal-title":"Tranfus Apher Sci"},{"key":"R38-1-20210209","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","article-title":". The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.","volume":"106","author":"Moreaux","year":"2005","journal-title":"Blood"},{"key":"R39-1-20210209","doi-asserted-by":"crossref","first-page":"16471","DOI":"10.18632\/oncotarget.4106","article-title":". Neutrophils trigger a NF-kappaB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas.","volume":"6","author":"Gregoire","year":"2015","journal-title":"Oncotarget"},{"key":"R40-1-20210209","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MPH.0b013e31829f3271","article-title":". Raised expression of APRIL in Chinese children with acute lymphoblastic leukemia and its clinical implications.","volume":"36","author":"Sun","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"R41-1-20210209","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.4049\/jimmunol.169.8.4314","article-title":". BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.","volume":"169","author":"Roschke","year":"2002","journal-title":"J Immunol"},{"key":"R42-1-20210209","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar2959","article-title":". B-lymphocyte stimulatora proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin.","volume":"12","author":"Dillon","year":"2010","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T18:32:06Z","timestamp":1654626726000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201604000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000549","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}